Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Aleksic T.,,Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells,2010,Cancer Research,133,10.1158/0008-5472.CAN-10-0052,United Kingdom,Article,Oxford,1,Journal,2-s2.0-77955736995
Yuen J.S.P.,,Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer,2009,Molecular Cancer Therapeutics,29,10.1158/1535-7163.MCT-09-0101,Singapore;United Kingdom,Article,Singapore City;Oxford,1,Journal,2-s2.0-67649371470
Pandini G.,,Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway,2009,Annals of the New York Academy of Sciences,13,10.1111/j.1749-6632.2009.04361.x,Italy,Conference Paper,Catania,0,Book Series,2-s2.0-61649120594
Chitnis M.M.,,The type 1 insulin-like growth factor receptor pathway,2008,Clinical Cancer Research,309,10.1158/1078-0432.CCR-07-4879,United Kingdom;United Kingdom,Review,Oxford;Oxford,1,Journal,2-s2.0-56749110996
Sutherland B.W.,,Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium,2008,Cancer Research,56,10.1158/0008-5472.CAN-07-6531,United States;Canada,Article,Seattle;Vancouver,1,Journal,2-s2.0-44849089393
Sroka I.,,Differential localization of MTI-MMP in human prostate cancer tissue: Role of IGF-IR in MTI-MMP expression,2008,Prostate,12,10.1002/pros.20718,United States,Article,Tucson,0,Journal,2-s2.0-41849116032
Narita S.,,Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis,2008,Prostate,20,10.1002/pros.20681,Japan,Article,Akita,0,Journal,2-s2.0-39449083288
Chiaverotti T.,,Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer,2008,American Journal of Pathology,152,10.2353/ajpath.2008.070602,United States,Article,San Francisco,0,Journal,2-s2.0-38749142915
Plymate S.,,An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer,2007,Clinical Cancer Research,52,10.1158/1078-0432.CCR-07-0648,United States;United States,Article,Seattle;Seattle,1,Journal,2-s2.0-35948940097
Yuen J.S.P.,,The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma,2007,Oncogene,72,10.1038/sj.onc.1210474,United Kingdom,Article,Oxford,1,Journal,2-s2.0-34948858983
Loblaw D.,,"Initial hormonal management of Androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 Update of an American society of clinical oncology practice guideline",2007,Journal of Clinical Oncology,422,10.1200/JCO.2006.10.1949,United States,Review,Alexandria,0,Journal,2-s2.0-34248169161
Mancuso A.,,Effective chemotherapy for hormone-refractory prostate cancer (HRPC): Present status and perspectives with taxane-based treatments,2007,Critical Reviews in Oncology/Hematology,33,10.1016/j.critrevonc.2006.09.001,Italy,Review,Rome,0,Journal,2-s2.0-33846203701
Samani A.,,The role of the IGF system in cancer growth and metastasis: Overview and recent insights,2007,Endocrine Reviews,779,10.1210/er.2006-0001,Canada;Canada,Review,Montreal;Hamilton,1,Journal,2-s2.0-33846874575
Collins R.,,A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer,2007,Health Technology Assessment,41,10.3310/hta11020,United Kingdom,Review,York,1,Journal,2-s2.0-85045482908
Huss W.,,Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model,2007,Neoplasia,55,10.1593/neo.07562,United States,Article,Buffalo,1,Journal,2-s2.0-36048989332
Yeh A.,,Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs,2006,Oncogene,43,10.1038/sj.onc.1209674,United Kingdom,Article,Oxford,1,Journal,2-s2.0-33748345653
Wu J.,,Interaction of IGF signaling and the androgen receptor in prostate cancer progression,2006,Journal of Cellular Biochemistry,134,10.1002/jcb.20929,United States,Review,Seattle,0,Journal,2-s2.0-33748927940
Gioeli D.,,"Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization",2006,Molecular Endocrinology,126,10.1210/me.2005-0351,United States;United States,Article,Charlottesville;Charlottesville,1,Journal,2-s2.0-33344467745
Liao Y.,,Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade,2005,Human Pathology,86,10.1016/j.humpath.2005.07.023,Germany;China,Article,Heidelberg;Wuhan,0,Journal,2-s2.0-27544501420
Pandini G.,,Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells,2005,Cancer Research,157,10.1158/0008-5472.CAN-04-1837,Italy,Article,Catania,1,Journal,2-s2.0-16444367879
Krueckl S.,,Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model,2004,Cancer Research,130,10.1158/0008-5472.CAN-04-2446,Canada,Article,Vancouver,1,Journal,2-s2.0-9244242088
Plymate S.R.,,Androgen Receptor (AR) expression in AR-Negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors,2004,Prostate,33,10.1002/pros.20099,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-5344261144
Petrylak D.P.,,Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer,2004,New England Journal of Medicine,2986,10.1056/NEJMoa041318,United States,Article,New York,0,Journal,2-s2.0-4744337716
Tannock I.,,Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer,2004,New England Journal of Medicine,4331,10.1056/NEJMoa040720,Canada;Canada,Article,Toronto;Toronto,0,Journal,2-s2.0-4744366279
Goya M.,,Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors,2004,Cancer Research,107,10.1158/0008-5472.CAN-04-0919,Japan,Article,Chuo-ku,1,Journal,2-s2.0-4344591505
Parker A.,,Pathologic T1 clear cell renal cell carcinoma: Insulin-like growth factor-I receptor expression and disease-specific survival,2004,Cancer,19,10.1002/cncr.20322,United States,Article,Jacksonville,1,Journal,2-s2.0-2642551431
Renehan A.G.,,"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis",2004,Lancet,1270,10.1016/S0140-6736(04)16044-3,United Kingdom,Article,Manchester,0,Journal,2-s2.0-1942436958
Zhao H.,,PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells,2004,Oncogene,116,10.1038/sj.onc.1207162,United States,Article,Bethesda,1,Journal,2-s2.0-1242272929
Rubin J.,,Prostate Carcinoma Cells That Have Resided in Bone Have an Upregulated IGF-I Axis,2004,Prostate,33,10.1002/pros.10299,United States;United States,Article,Decatur;Atlanta,0,Journal,2-s2.0-0346725927
Grzmil M.,,"Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3 and suppresses MMP-2 expression",2004,Journal of Pathology,65,10.1002/path.1492,Germany,Review,Gottingen,0,Journal,2-s2.0-0346656569
Bhattacharyya R.S.,,IGF-I and MAP Kinase Involvement in the Stimulatory Effects of LNCaP Prostate Cancer Cell Conditioned Media on Cell Proliferation and Protein Synthesis in MC3T3-E1 Osteoblastic Cells,2003,Journal of Cellular Biochemistry,9,10.1002/jcb.10726,United States,Article,Chicago,0,Journal,2-s2.0-0345017075
Cardillo M.,,"Insulin-like Growth Factor (IGF)-I, IGF-II and IGF Type I Receptor (IGFR-I) Expression in Prostatic Cancer",2003,Anticancer Research,76,,Italy,Article,Rome,0,Journal,2-s2.0-0345392848
Bohula E.A.,,The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript,2003,Journal of Biological Chemistry,214,10.1074/jbc.M300714200,United Kingdom,Article,Oxford,1,Journal,2-s2.0-0038521255
Hellawell G.O.,,Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor,2003,BJU International,61,10.1046/j.1464-410X.2003.04061.x,United Kingdom;United Kingdom,Article,Oxford;Oxford,0,Journal,2-s2.0-0037326983
Hellawell G.O.,,Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease,2002,Cancer Research,307,,United Kingdom;United Kingdom,Article,Oxford;Oxford,0,Journal,2-s2.0-0037092971
Parker A.,,High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas,2002,Human Pathology,40,10.1053/hupa.2002.126186,United States,Article,Rochester,0,Journal,2-s2.0-0036692208
Shi R.,,Insulin-like growth factor-I and prostate cancer: A meta-analysis,2001,British Journal of Cancer,106,10.1038/sj.bjc.6691961,United States;United States,Article,Shreveport;Shreveport,1,Journal,2-s2.0-0035964587
Nickerson T.,,In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR),2001,Cancer Research,199,,Canada,Article,Montreal,0,Journal,2-s2.0-0035881876
Macaulay V.M.,,Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase,2001,Oncogene,109,10.1038/sj.onc.1204565,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035811559
Gregory C.,,A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy,2001,Cancer Research,503,,United States,Article,Chapel Hill,0,Journal,2-s2.0-0035361340
Figueroa J.A.,,Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: Correlation with clinico-pathological parameters,2001,Cancer Investigation,23,10.1081/CNV-100000072,United States,Article,Lubbock,0,Journal,2-s2.0-0035082281
Damon S.,,Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells,2001,Endocrinology,47,10.1210/endo.142.1.7890,United States;United States,Article,Seattle;Tacoma,1,Journal,2-s2.0-0035114948
Chokkalingam A.P.,,Insulin-like growth factors and prostate cancer: A population-based case-control study in china,2001,Cancer Epidemiology Biomarkers and Prevention,151,,United States,Article,Bethesda,0,Journal,2-s2.0-0034916063
Stattin P.,,"Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study",2000,Journal of the National Cancer Institute,334,10.1093/jnci/92.23.1910,Sweden,Article,Umea,1,Journal,2-s2.0-0034614104
Finne P.,,Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen,2000,Journal of Clinical Endocrinology and Metabolism,74,10.1210/jc.85.8.2744,Finland,Article,Helsinki,0,Journal,2-s2.0-17744364495
Reiss K.,,IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation,2000,Oncogene,74,10.1038/sj.onc.1203587,United States,Article,Philadelphia,1,Journal,2-s2.0-0034682328
DiGiovanni J.,,Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice,2000,Proceedings of the National Academy of Sciences of the United States of America,234,10.1073/pnas.97.7.3455,United States,Article,Smithville,1,Journal,2-s2.0-12944335316
Harman S.,,"Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer",2000,Journal of Clinical Endocrinology and Metabolism,199,10.1210/jcem.85.11.6990,United States;United States,Article,Bethesda;Phoenix,1,Journal,2-s2.0-0034527640
McMenamin M.,,Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage,1999,Cancer Research,542,,United States,Article,Boston,0,Journal,2-s2.0-0033200172
Kaplan P.,,The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model,1999,Cancer Research,186,,,Article,,0,Journal,2-s2.0-0033135898
Chott A.,,Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor,1999,American Journal of Pathology,145,10.1016/S0002-9440(10)65229-7,Austria;United States,Article,Vienna;Boston,0,Journal,2-s2.0-0032877615
Eisenberger M.,,Bilateral orchiectomy with or without flutamide for metastatic prostate cancer,1998,New England Journal of Medicine,733,10.1056/NEJM199810083391504,United States;United States,Article,Ann Arbor;Baltimore,0,Journal,2-s2.0-0032497522
Wolk A.,,"Insulin-like growth factor 1 and prostate cancer risk: A population- based, case-control study",1998,Journal of the National Cancer Institute,500,10.1093/jnci/90.12.911,Sweden,Article,Stockholm,1,Journal,2-s2.0-0032540667
Chan J.M.,,Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study,1998,Science,1713,10.1126/science.279.5350.563,United States,Article,Boston,0,Journal,2-s2.0-0032559272
Turner B.C.,,Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation,1997,Cancer Research,321,,United States,Article,New Haven,0,Journal,2-s2.0-16944364325
Plymate S.,,Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells,1997,Endocrinology,58,10.1210/endo.138.4.5071,United States;United States;United States,Article,Seattle;;Tacoma,1,Journal,2-s2.0-0030960834
Tennant M.,,Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin- like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium,1996,Journal of Clinical Endocrinology and Metabolism,158,10.1210/jc.81.10.3774,United States;United States,Article,Seattle;,0,Journal,2-s2.0-0029826841
Greenberg N.,,Prostate cancer in a transgenic mouse,1995,Proceedings of the National Academy of Sciences of the United States of America,1019,10.1073/pnas.92.8.3439,United States,Article,Houston,1,Journal,2-s2.0-0028911462
Sell C.,,Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts,1994,Molecular and Cellular Biology,479,10.1128/MCB.14.6.3604,United States,Article,Philadelphia,1,Journal,2-s2.0-0028332092
Denis L.,,Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer,1993,Cancer,187,10.1002/1097-0142(19931215)72:12+<3888::AID-CNCR2820721726>3.0.CO;2-B,Belgium,Article,Antwerpen,0,Journal,2-s2.0-0027369623
Iwamura M.,,Insulin‐like growth factor I: Action and receptor characterization in human prostate cancer cell lines,1993,The Prostate,195,10.1002/pros.2990220307,United States,Article,Rochester,0,Journal,2-s2.0-0027152122
Baker J.,,Role of insulin-like growth factors in embryonic and postnatal growth,1993,Cell,1903,10.1016/S0092-8674(05)80085-6,United States,Article,New York,0,Journal,2-s2.0-0027423419
Soos M.,,"A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity",1992,Journal of Biological Chemistry,100,,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0026632363
Hauschka P.,,Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose,1986,Journal of Biological Chemistry,719,,United States,Article,Boston,0,Journal,2-s2.0-0023037767
